When was Aster Insights founded?

Aster Insights was founded in 2006 and raised its 1st funding round 11 years after it was founded.

Where is Aster Insights located?

Aster Insights is headquartered in Tampa, United States. It is registered at Tampa, Florida.

How many employees does Aster Insights have?

As of Mar 31, 2026, the latest employee count at Aster Insights is 37.

Is Aster Insights a funded company?

Aster Insights is a funded company, having raised a total of $75M across 2 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Sep 20, 2017.

When was the latest funding round of Aster Insights?

Aster Insights' latest funding was a $***** Series C round on Mar 17, 2021, with participation from 7 investors.

Where does Aster Insights rank among its competitors?

Aster Insights ranks 4th amongst 104 active competitors, of which 14 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Tharimmune, which secured $545M in Nov, 2025.

Who are the top competitors of Aster Insights?

Aster Insights' top competitors include CancerVax, OnCusp and Linical. Among them, Tharimmune secured the most recent funding round in November, 2025.

Aster Insights - 2026 Company Profile, Funding & Competitors

Aster Insights is a series C company based in Tampa (United States), founded in 2006. It operates as a Provider of contract based oncology clinical trial services. Aster Insights has raised $75M in funding from investors like Clayton Dubilier & Rice, Clayton Homes and Hearst. The company has 104 active competitors, including 14 funded and 16 that have exited. Its top competitors include companies like CancerVax, OnCusp and Linical.

Company Details

Website: asterinsights.com
Social
Email ID: *****@asterinsights.com
Phone Number: +1 **********
Registered Address: Tampa, Florida

Key Metrics

Founded Year

2006

Location

Tampa, United States

Stage

Series C

Total Funding

$75M in 2 rounds

Latest Funding Round

Series C, Mar 17, 2021, $*****

Investors

Clayton Dubilier & Rice & 7 more

Ranked

4^th among 104 active competitors

Employee Count

37 as on Mar 31, 2026

Similar Companies

CancerVax & 116 more

View Aster Insights' full profile

Aster Insights is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
M2GEN, CORP. CIN: 208486180 , United States, Active	Dec 31, 1999	-	92 (As on Dec 31, 2023)	-

Aster Insights has raised a total funding of $75M over 2 rounds. Its first funding round was on Sep 20, 2017. Its latest funding round was a Series C round on Mar 17, 2021 for $*****. 7 investors participated in its latest round. Aster Insights has 8 institutional investors.

Here is the list of recent funding rounds of Aster Insights:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 17, 2021	6831227	Series C	7786491	5569369	6095477	8604046
Sep 20, 2017	5131835	Series B	2920275	8641264	Hearst	9994602

Access funding benchmarks and valuations. Sign up today!

View details of Aster Insights's funding rounds and investors

Aster Insights' employee count trend

Aster Insights has 37 employees as of Mar 26. Here is Aster Insights's employee count trend over the years:

Uncover Aster Insights' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Aster Insights include CancerVax, OnCusp and Linical. Here is the list of Top 10 competitors of Aster Insights, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	CancerVax 1998, Carlsbad (United States), Series B	Limited information available	$58M	Athenian Venture Partners, endpointgroup.com ... & 11 others	50/100
2nd	OnCusp 2021, New York City (United States), Series A	CRO offering clinical development services for oncology drugs	$139M	Orbimed, F-Prime Capital & 8 others	49/100
3rd	Linical 2005, Osaka (Japan), Public	Full service CRO with presence in 20+ countries	-	Japan Asia Investment, SBIC West Japan	48/100
4th	Aster Insights 2006, Tampa (United States), Series C	Provider of contract based oncology clinical trial services	$75M	McKesson Ventures, Merck Global Health Innovation Fund ... & 6 others	37/100
5th	Oncotherapeutics 1988, West Hollywood (United States), Acquired	CRO focused on community oncology research, improving cancer therapies' clinical utility	$8.3M	Domain Associates, TVM Capital	44/100
6th	Medivir 1998, Sweden, Public	Medivir - Science working wonders	-	-	41/100
7th	Actithera 2021, Cambridge (United States), Series A	Radiopharmaceutical company developing novel radiotherapeutics for the treatment of cancer through its unique medicinal chemistry platform	$80.8M	M Ventures, 4Bio Capital & 7 others	39/100
8th	Vivia Biotech 2007, Tres Cantos (Spain), Series A	Developer of precision medicine test for hematologic cancers	$7.52M	Suanfarma, Clave	39/100
9th	Medelis 2003, Nashville (United States), Acquired	Oncology CRO providing expert clinical trial management for drug development	-	-	39/100
10th	Tharimmune 2023, Bridgewater (United States), Public	Clinical-stage biotechnology company developing a portfolio of therapeutic candidates for rare, inflammatory, and oncologic conditions	-	Liberty City Ventures, DRW Trading Group ... & 25 others	38/100